Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Ponte

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|February 25, 2005
Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differMatilde Gracia, Carmina Martínez-Marín, Lorena Huelves, et al.
International Journal of Antimicrobial Agents|March 23, 2010
Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococciVioleta Rodríguez-Cerrato, Gema Del Prado, Lorena Huelves, et al.
Microbial Pathogenesis|June 23, 2007
Adherence of Streptococcus pneumoniae to polystyrene plates, effect of serum on adhesion, and virulence in the gerbil otitis media modelLorena Huelves, Gema del Prado, Violeta Rodriguez-Cerrato, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2007
In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strainsVioleta Rodríguez-Cerrato, Pedro García, Gema Del Prado, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniaeVioleta Rodríguez-Cerrato, Pedro García, Lorena Huelves, et al.
The Journal of Antimicrobial Chemotherapy|September 8, 2005
Effect of erythromycin treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniaeCarmina Martínez-Marín, Lorena Huelves, Gema del Prado, et al.
Pediatric Research|September 13, 2006
Impact of ibuprofen therapy in the outcome of experimental pneumococcal acute otitis media treated with amoxicillin or erythromycinGema del Prado, Carmina Martínez-Marín, Lorena Huelves, et al.
International Journal of Antimicrobial Agents|March 11, 2006
Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolonesLorena Huelves, David Sevillano, Carmina Martínez-Marín, et al.
Microbial Pathogenesis|May 20, 2008
Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strainsPlínio Naves, Gema del Prado, Lorena Huelves, et al.
BMC Microbiology|September 24, 2009
Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC)Margarita Martinez-Medina, Plínio Naves, Jorge Blanco, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|February 25, 2005
Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differMatilde Gracia, Carmina Martínez-Marín, Lorena Huelves, et al.
International Journal of Antimicrobial Agents|March 23, 2010
Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococciVioleta Rodríguez-Cerrato, Gema Del Prado, Lorena Huelves, et al.
Microbial Pathogenesis|June 23, 2007
Adherence of Streptococcus pneumoniae to polystyrene plates, effect of serum on adhesion, and virulence in the gerbil otitis media modelLorena Huelves, Gema del Prado, Violeta Rodriguez-Cerrato, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2007
In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strainsVioleta Rodríguez-Cerrato, Pedro García, Gema Del Prado, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniaeVioleta Rodríguez-Cerrato, Pedro García, Lorena Huelves, et al.
The Journal of Antimicrobial Chemotherapy|September 8, 2005
Effect of erythromycin treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniaeCarmina Martínez-Marín, Lorena Huelves, Gema del Prado, et al.
Pediatric Research|September 13, 2006
Impact of ibuprofen therapy in the outcome of experimental pneumococcal acute otitis media treated with amoxicillin or erythromycinGema del Prado, Carmina Martínez-Marín, Lorena Huelves, et al.
International Journal of Antimicrobial Agents|March 11, 2006
Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolonesLorena Huelves, David Sevillano, Carmina Martínez-Marín, et al.
Microbial Pathogenesis|May 20, 2008
Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strainsPlínio Naves, Gema del Prado, Lorena Huelves, et al.
BMC Microbiology|September 24, 2009
Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC)Margarita Martinez-Medina, Plínio Naves, Jorge Blanco, et al.
Pageof 3